Irbesartan Tablet
Product Images NDC 70518-2245

4 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 70518-2245). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Irbesartanfigure3

Irbesartanfigure3
A line graph showing the cumulative event rate (%) over months of follow-up for three groups: Irbesartan, Amlodipine, and Placebo. The graph compares the incidence of events among the groups during a 60-month period, with statistical values provided for Irbesartan versus Placebo and Irbesartan versus Amlodipine.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Irbesartan 150 mg oral tablets packaging label from RemedyRepack Inc. The label indicates 90 tablets per bottle, includes the product NDC 70518-2245, and manufacturer information for Camber Pharma, Inc. It also contains storage instructions and a QR code.*
FDA Label Image

Image1

Image1
Chemical structure of Irbesartan, showing its molecular framework with connected rings and functional groups, including nitrogen atoms and characteristic side chains.*
FDA Label Image

Image2

Image2
Two scatter plots with trend lines depicting placebo-subtracted reductions in trough SeSBP and diastolic blood pressure versus Irbesartan dose (mg/day). The first graph shows systolic pressure changes, and the second graph shows diastolic pressure changes, each with data points and dose ranges from 0 to about 900 mg/day.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.